Market Overview

Corgenix Announces Collaboration with Lilly


Medical Corporation (OTC: CONX), a worldwide developer and
marketer of diagnostic test kits, announced today that it has entered
into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) to
develop diagnostic technology in support of a Lilly oncology pipeline
program. Under the terms of the agreement, the two companies will
collaborate to further advance this proprietary diagnostic technology
originally developed by Lilly. The financial terms of the agreement were
not disclosed.

“We are very pleased to enter into this new and exciting collaboration
with Lilly,” said Douglass Simpson, President and CEO of Corgenix, “This
relationship strengthens our company's program of strategic alliances in
key areas of laboratory and

See full press release

Posted-In: News Guidance Contracts Management M&A Global


Related Articles (LLY CONX)

View Comments and Join the Discussion!